Major and minor salivary glands tumours

Lisa Licitra, Cesare Grandi, Franz Josef Prott, Jan H. Schornagel, Paulo Bruzzi, Roberto Molinari

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Malignant salivary gland tumours are rare. The most common tumour site is the parotid. Aetiologic factors are not clear. Nutrition may be a risk factor, as well as irradiation or an histologically benign tumour occurred at a young age. Painless swelling of a salivary gland should always be considered as suspicious, especially if no sign of inflammation is present. Signs and symptoms related to major salivary gland tumours differ from those concerning minor salivary gland tumours, as they depend on the different location of the salivary gland. Surgical excision represents the standard option in the treatment of resectable tumours of both major and minor salivary glands. Neutron radiation may be a treatment option for inoperable locoregional disease. Surgery, irradiation or re-irradiation are treatment options for local relapse, whereas radical neck dissection is indicated for regional relapses. Metastastic disease may be either treated with radiotherapy or palliative chemotherapy, depending on the site of metastases.

Original languageEnglish
Pages (from-to)215-225
Number of pages11
JournalCritical Reviews in Oncology/Hematology
Volume45
Issue number2
DOIs
Publication statusPublished - Feb 1 2003

Fingerprint

Minor Salivary Glands
Glandular and Epithelial Neoplasms
Salivary Glands
Recurrence
Neoplasms
Neck Dissection
Neutrons
Signs and Symptoms
Radiotherapy
Therapeutics
Radiation
Neoplasm Metastasis
Inflammation
Drug Therapy

Keywords

  • Carcinomas
  • Salivary glands
  • Tumours

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Major and minor salivary glands tumours. / Licitra, Lisa; Grandi, Cesare; Prott, Franz Josef; Schornagel, Jan H.; Bruzzi, Paulo; Molinari, Roberto.

In: Critical Reviews in Oncology/Hematology, Vol. 45, No. 2, 01.02.2003, p. 215-225.

Research output: Contribution to journalArticle

Licitra, Lisa ; Grandi, Cesare ; Prott, Franz Josef ; Schornagel, Jan H. ; Bruzzi, Paulo ; Molinari, Roberto. / Major and minor salivary glands tumours. In: Critical Reviews in Oncology/Hematology. 2003 ; Vol. 45, No. 2. pp. 215-225.
@article{9a8eda816951451fbb67bbf2a0b6f33d,
title = "Major and minor salivary glands tumours",
abstract = "Malignant salivary gland tumours are rare. The most common tumour site is the parotid. Aetiologic factors are not clear. Nutrition may be a risk factor, as well as irradiation or an histologically benign tumour occurred at a young age. Painless swelling of a salivary gland should always be considered as suspicious, especially if no sign of inflammation is present. Signs and symptoms related to major salivary gland tumours differ from those concerning minor salivary gland tumours, as they depend on the different location of the salivary gland. Surgical excision represents the standard option in the treatment of resectable tumours of both major and minor salivary glands. Neutron radiation may be a treatment option for inoperable locoregional disease. Surgery, irradiation or re-irradiation are treatment options for local relapse, whereas radical neck dissection is indicated for regional relapses. Metastastic disease may be either treated with radiotherapy or palliative chemotherapy, depending on the site of metastases.",
keywords = "Carcinomas, Salivary glands, Tumours",
author = "Lisa Licitra and Cesare Grandi and Prott, {Franz Josef} and Schornagel, {Jan H.} and Paulo Bruzzi and Roberto Molinari",
year = "2003",
month = "2",
day = "1",
doi = "10.1016/S1040-8428(02)00005-7",
language = "English",
volume = "45",
pages = "215--225",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Major and minor salivary glands tumours

AU - Licitra, Lisa

AU - Grandi, Cesare

AU - Prott, Franz Josef

AU - Schornagel, Jan H.

AU - Bruzzi, Paulo

AU - Molinari, Roberto

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Malignant salivary gland tumours are rare. The most common tumour site is the parotid. Aetiologic factors are not clear. Nutrition may be a risk factor, as well as irradiation or an histologically benign tumour occurred at a young age. Painless swelling of a salivary gland should always be considered as suspicious, especially if no sign of inflammation is present. Signs and symptoms related to major salivary gland tumours differ from those concerning minor salivary gland tumours, as they depend on the different location of the salivary gland. Surgical excision represents the standard option in the treatment of resectable tumours of both major and minor salivary glands. Neutron radiation may be a treatment option for inoperable locoregional disease. Surgery, irradiation or re-irradiation are treatment options for local relapse, whereas radical neck dissection is indicated for regional relapses. Metastastic disease may be either treated with radiotherapy or palliative chemotherapy, depending on the site of metastases.

AB - Malignant salivary gland tumours are rare. The most common tumour site is the parotid. Aetiologic factors are not clear. Nutrition may be a risk factor, as well as irradiation or an histologically benign tumour occurred at a young age. Painless swelling of a salivary gland should always be considered as suspicious, especially if no sign of inflammation is present. Signs and symptoms related to major salivary gland tumours differ from those concerning minor salivary gland tumours, as they depend on the different location of the salivary gland. Surgical excision represents the standard option in the treatment of resectable tumours of both major and minor salivary glands. Neutron radiation may be a treatment option for inoperable locoregional disease. Surgery, irradiation or re-irradiation are treatment options for local relapse, whereas radical neck dissection is indicated for regional relapses. Metastastic disease may be either treated with radiotherapy or palliative chemotherapy, depending on the site of metastases.

KW - Carcinomas

KW - Salivary glands

KW - Tumours

UR - http://www.scopus.com/inward/record.url?scp=0037320077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037320077&partnerID=8YFLogxK

U2 - 10.1016/S1040-8428(02)00005-7

DO - 10.1016/S1040-8428(02)00005-7

M3 - Article

VL - 45

SP - 215

EP - 225

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 2

ER -